Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

4.1K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.1K
iPS Cell Differentiation01:22

iPS Cell Differentiation

2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Stem Cell Culture01:17

Stem Cell Culture

5.2K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.2K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Effect of Telehealth on Cost of Health Care During the COVID-19 Pandemic: A Systematic Review.

Telemedicine journal and e-health : the official journal of the American Telemedicine Association·2024
Same author

The role of increasing synchronous telehealth use during the COVID-19 pandemic on disparities in access to healthcare: A systematic review.

Journal of telemedicine and telecare·2024
Same author

Telehealth Use and Health Equity for Mental Health and Substance Use Disorder During the COVID-19 Pandemic: A Systematic Review.

Telemedicine journal and e-health : the official journal of the American Telemedicine Association·2024
Same author

Predictors of Survival After Emergent Surgical Decompression for Acutely Presenting Spinal Metastasis.

World neurosurgery·2023
Same author

Usability and feasibility assessment of a smartphone application (Suhriday) for heart failure self-care remote monitoring in an Indian tertiary health care setting: a pilot mixed-methods study.

BMJ open·2022
Same author

A qualitative, grounded theory exploration of the determinants of self-care behavior among Indian patients with a lived experience of chronic heart failure.

PloS one·2021

Related Experiment Video

Updated: Jul 6, 2025

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies
12:13

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies

Published on: July 11, 2019

7.2K

The Challenges to Advancing Induced Pluripotent Stem Cell-Dependent Cell Replacement Therapy.

Alan B Moy1,2, Anant Kamath1, Sara Ternes1

  • 1Cellular Engineering Technologies, Inc. Coralville, IA, 52241.

Medical Research Archives
|January 8, 2024
PubMed
Summary

Induced pluripotent stem cells (iPSC) offer regenerative medicine potential but face significant safety and technical hurdles. Addressing challenges in reprogramming, genetic stability, and scalability is crucial for realizing iPSC therapies.

More Related Videos

Scalable 96-well Plate Based iPSC Culture and Production Using a Robotic Liquid Handling System
08:00

Scalable 96-well Plate Based iPSC Culture and Production Using a Robotic Liquid Handling System

Published on: May 14, 2015

31.7K
Derivation of Adult Human Fibroblasts and their Direct Conversion into Expandable Neural Progenitor Cells
13:58

Derivation of Adult Human Fibroblasts and their Direct Conversion into Expandable Neural Progenitor Cells

Published on: July 29, 2015

15.5K

Related Experiment Videos

Last Updated: Jul 6, 2025

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies
12:13

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies

Published on: July 11, 2019

7.2K
Scalable 96-well Plate Based iPSC Culture and Production Using a Robotic Liquid Handling System
08:00

Scalable 96-well Plate Based iPSC Culture and Production Using a Robotic Liquid Handling System

Published on: May 14, 2015

31.7K
Derivation of Adult Human Fibroblasts and their Direct Conversion into Expandable Neural Progenitor Cells
13:58

Derivation of Adult Human Fibroblasts and their Direct Conversion into Expandable Neural Progenitor Cells

Published on: July 29, 2015

15.5K

Area of Science:

  • Regenerative Medicine
  • Stem Cell Biology
  • Biotechnology

Background:

  • Induced pluripotent stem cells (iPSCs) hold promise for treating chronic diseases like macular degeneration and neurodegenerative disorders.
  • The iPSC therapeutic field is nascent, involving academia, industry, regulators, and patients.
  • iPSC therapies present unique challenges in safety, potency, genetic stability, immunogenicity, tumorigenicity, reproducibility, scalability, and engraftment compared to traditional therapeutics.

Purpose of the Study:

  • To review the unique technical challenges hindering the clinical application of iPSC technology.
  • To propose potential solutions and identify key areas for advancement in iPSC therapeutics.
  • To cover reprogramming methods, genetic stability, differentiation, gene editing, cell therapy types, regulatory aspects, and engraftment factors.

Main Methods:

  • Review of current literature on iPSC reprogramming, differentiation, and therapeutic applications.
  • Analysis of technical challenges including immunogenicity, tumorigenicity, genetic stability, and scalability.
  • Exploration of potential solutions such as gene editing and optimized growth factor use.
  • Discussion of autologous vs. allogeneic cell therapy, regulatory considerations, and engraftment factors.

Main Results:

  • Different iPSC reprogramming methods impact immunogenicity and tumorigenicity.
  • Genetic instability affects cell reproducibility and differentiation potential.
  • Growth factors and post-translational modifications influence differentiation and scalability.
  • Gene editing may enhance iPSC differentiation.
  • Autologous and allogeneic therapies have distinct advantages and disadvantages.
  • Regulatory pathways and local inflammation impact cell product viability and engraftment.

Conclusions:

  • Overcoming technical challenges in iPSC reprogramming, genetic stability, differentiation, and scalability is essential for therapeutic realization.
  • Careful consideration of cell therapy type, regulatory requirements, and engraftment factors is necessary for successful iPSC product development.
  • Further research and strategic focus are required to translate iPSC potential into effective cell replacement therapies.